openPR Logo
Press release

Scopolamine Market Upcoming Trends and Future Growth Analysis till 2026 with Prominent Key Players such as Baxter International Inc., GlaxoSmithKline plc. Novartis AG, Perrigo Company plc., Caleb Pharmaceuticals, Inc.

04-25-2019 06:27 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Scopolamine

Scopolamine

Scopolamine is an alkaloid drug extracted from plant called henbane to treat nausea and motion sickness and further to dilate the pupil in ophthalmic procedures. Scopolamine belongs to a class of drugs called anticholinergics. It works by blocking the activity of the neurotransmitter acetylcholine, which stimulates the part of the brain that triggers nausea and vomiting, involuntary muscle movement in the lungs, and the gastrointestinal and urinary tracts. Scopolamine is also used in medicine as a sedative or hypnotic and sometimes with morphine to relieve pain. Scopolamine has also been prescribed ‘off label’ for depression, asthma, as a smoking-cessation remedy, and to relieve the nausea that accompanies chemotherapy.

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1965

The global scopolamine market size was valued at US$ 370.4 million in 2017, and is expected to witness a CAGR of 4.8% over the forecast period (2018 – 2026).

Scopolamine Market- Competitive Landscape

Key players operating in the global scopolamine market include Baxter International Inc., GlaxoSmithKline plc. Novartis AG, Perrigo Company plc., Caleb Pharmaceuticals, Inc., Myungmoon Pharma Co. LTD., Alchem International, Phytex Australia, Centroflora-Cms, Alkaloids of Australia, and Fine Chemicals Corporation.

Increasing prevalence of motion sickness is expected to drive growth of the scopolamine market

Psychological stress is considered as one of the most important factors in the development of motion sickness. The psychological stress impacts intestinal motility, intestinal sensitivity, permeability, and secretion that is co-related with the mucosal immune activation and alterations in the central nervous system. According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. Thus, increasing number of population suffering from stress and anxiety disorder are expected to fuel growth of the global scopolamine market. Use of scopolamine in Alzheimer's disease may prove useful as a diagnostic or staging test in the evaluation of the cholinergic system in dementia, which provides opportunities to the researchers to explore application of these drugs for other neurological disorders, which in turn is driving the market growth over the forecast period.

Scopolamine Market- Regional Analysis

Scopolamine market is segmented into six major regions- North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Increasing consumption of unhealthy food leading to obesity and other stomach related infections act as one of the major factors driving growth of the scopolamine market in North America region. According to an article published in the Brandon Gaille, in 2017, junk food accounts for 28.8% of the total caloric intake of an average American. Consumption of unhealthy food in large quantity increases the risk of developing irritable bowel syndrome, which is acting as a driving factor for the global scopolamine market growth.

Detailed Segmentation:

Global Scopolamine Market, By Dosage Form:
Tablet
Syrup
Injection
Patch
Others

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/1965

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Scopolamine Market Upcoming Trends and Future Growth Analysis till 2026 with Prominent Key Players such as Baxter International Inc., GlaxoSmithKline plc. Novartis AG, Perrigo Company plc., Caleb Pharmaceuticals, Inc. here

News-ID: 1717026 • Views:

More Releases from Coherent Market Insights

Heart-on-a-chip Market Witness Growth: Booming Demand and Market Trends 2025-2032
Heart-on-a-chip Market Witness Growth: Booming Demand and Market Trends 2025-203 …
The global Heart-on-a-chip Market is expected to grow at 35.21% CAGR from 2025 to 2032. 𝐓𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐫𝐞𝐬𝐮𝐥𝐭 𝐨𝐟 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐞𝐝 𝐛𝐲 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦 𝐨𝐟 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 - 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited companies Coverage of the Heart-on-a-chip Market: The
Nano Bioreactor Market Booming Trends: Industry Dynamics and Future Expansion 2025-2032 | Eppendorf, Merck
Nano Bioreactor Market Booming Trends: Industry Dynamics and Future Expansion 20 …
The global Nano Bioreactor Market is expected to grow at 8.5% CAGR from 2025 to 2032. 𝐓𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐫𝐞𝐬𝐮𝐥𝐭 𝐨𝐟 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐞𝐝 𝐛𝐲 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦 𝐨𝐟 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 - 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited companies Coverage of the Nano
GI Stool Testing Market Booming Demand: Innovation, Forecast, and Market Size 2025-2032 | BD, DiaSorin, GenProbe Incorporated, Alere, Inc.
GI Stool Testing Market Booming Demand: Innovation, Forecast, and Market Size 20 …
The global GI Stool Testing Market is expected to grow at 8.5% CAGR from 2025 to 2032. 𝐓𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐫𝐞𝐬𝐮𝐥𝐭 𝐨𝐟 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐞𝐝 𝐛𝐲 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦 𝐨𝐟 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 - • 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited companies Coverage
Haptic VR Device Market Witness Rapid Growth: Future Trends and Market Expansion …
The global Haptic VR Device Market is expected to grow at 16.8% CAGR from 2025 to 2032. 𝐓𝐡𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐬 𝐭𝐡𝐞 𝐫𝐞𝐬𝐮𝐥𝐭 𝐨𝐟 𝐞𝐱𝐭𝐞𝐧𝐬𝐢𝐯𝐞 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐜𝐨𝐧𝐝𝐮𝐜𝐭𝐞𝐝 𝐛𝐲 𝐨𝐮𝐫 𝐭𝐞𝐚𝐦 𝐨𝐟 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞𝐝 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 - 70% efforts of Primary Research • 15% efforts of Secondary Research • 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited companies Coverage of the

All 5 Releases


More Releases for Scopolamine

Scopolamine Market With Four Main Geographies And Their Countries
This research study on "Scopolamine market" reports offers the comparative assessment of Scopolamine market and consist of Historical data, Significance, statistical data, size & share, Market Price & Demand, Business overview, Market Analysis By Product and Market Trends by Key Players. This Scopolamine Market is Segmented in two type on the basis of type of materials and end-users. It has global market covered in all the regions, ranging to that
Global Scopolamine Market Study 2015-2025, by Segment (Scopolamine Butylbromide, …
Scopolamine is a medication used in the treatment of motion sickness and postoperative nausea and vomiting. Scopolamine is used to prevent nausea and vomiting caused by motion sickness or from anesthesia given during surgery. The global Scopolamine market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): Download exclusive Sample of this report:
Scopolamine Market CAGR, Key Players, Applications, Products and Regions
The Scopolamine market report gives CAGR value, Industry Chains, Upstream, Geography, End user, Application, Competitor analysis, SWOT Analysis, Sales, Revenue, Price, Gross Margin, Market Share, Import-Export, Trends and Forecast. The report also gives insight on entry and exit barriers of the industry. The Scopolamine market report covers major Manufactures Centroflora-cms, Fine Chemicals Corporation, Phytex Australia, Alchem International, Guangzhou Hanfang, Alkaloids Corporation, Luyin. Initially report provides information about Scopolamine Market Scenario, Development Prospect,
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the
Global Transdermal Scopolamine Market 2018 - Novartis, GlaxoSmithKline, Perrigo
The statistical surveying information incorporated into the Transdermal Scopolamine report is the aftereffect of significant essential and optional research exercises. The report fragments the global market for Transdermal Scopolamine based on makers, item compose, applications, and districts. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the global Transdermal Scopolamine advertise covering key factors, for example, drivers and
Transdermal Scopolamine Market | Comprehensive Analysis and Future Estimations 2 …
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of The Global Transdermal Scopolamine Market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the